Table 2.
Carrageenan | PCX | |
---|---|---|
Immune cell trafficking | 7.74E−09 | 7.74E−09 |
Inflammatory response | 7.74E−09 | 7.74E−09 |
Cellular compromise | 1.56E−06 | 1.56E−06 |
Nervous system development and function | 9.23E−06 | 9.23E−06 |
Hypersensitivity response | 2.11E−05 | 2.11E−05 |
Neurological disease | 2.46E−05 | 2.46E−05 |
Based on mRNA expression data quantified from the ipsilateral dorsal horn of rats received either carrageenan or paclitaxel compared to their respective controls (n = 5-7 in each group)
Data were generated using low-density microarray cards. Results shown represent the -log of p values calculated by Fisher’s exact test right tailed (p < 0.05)